fda regulation of cell and gene therapies: facilitating advanced manufacturing
Published 4 years ago • 4.4K plays • Length 28:51Download video MP4
Download video MP3
Similar videos
-
16:25
fda’s efforts to advance the development and approval of cellular and gene therapies
-
36:56
fda’s clinical regulatory perspective: designing first-in-human trial for cellular and gene therapy
-
25:56
advanced topics successful development of quality cell and gene therapy products
-
29:42
cmc considerations for car t cell product development
-
29:58
an update on the office of cellular, tissue and gene therapies: celia witten, fda
-
1:32
importance of international harmonization in cell & gene therapies
-
17:14
real-world challenge: establishing the value of gene therapy for patients
-
58:27
the fda's role in gene therapy
-
2:40
the changing landscape of hospital-based cell and gene therapy manufacturing
-
24:29
meeting regulatory requirements for cell and gene therapy manufacturing
-
1:51
navigate the complexities of cell and gene therapies with regulatory and cmc expertise
-
46:52
preclinical considerations for cell and gene therapy products, an fda perspective
-
1:29
cmc challenges in cell and gene therapy manufacturing
-
0:46
gene therapy for the sickle cell diseases is approved by the fda
-
8:39:50
75th cellular, tissue, and gene therapies advisory committee
-
2:05
the challenges of cmc in cell and gene therapies
-
1:11:32
next steps for cell and gene therapies
-
37:14
2022 wmif | gene and cell therapy | the world speaks
-
40:05
"gene therapy- unlocking the promise" peter marks, fda